RPG Life Sciences Limited

RPG Life Sciences Limited

RPG Life Sciences Limited held its Nineteenth Annual General Meeting (AGM) on July 23, 2026, where all resolutions were passed with a requisite majority. The meeting was conducted through video conferencing, and the company provided remote e-voting and e-voting facilities for shareholders. The AGM concluded with the Chairman thanking the members for attending and declaring the meeting as concluded.

RPG Life Sciences Limited

RPG Life Sciences Limited held its 19th Annual General Meeting (AGM) on July 23, 2026, where all resolutions were passed with a requisite majority. The meeting was conducted through video conferencing, and the company provided remote e-voting and e-voting facilities for members. The AGM concluded with the adoption of financial statements for FY 2025-26 and the declaration of a 300% dividend.

RPG Life Sciences Limited

RPG Life Sciences Limited has received a certificate from MUFG Intime India Private Limited confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, related to dematerialization of securities.

RPG Life Sciences Limited

RPG Life Sciences has partnered with Archerchem Healthcare to launch Naprosyn ES, a combination of Naproxen and Esomeprazole, in India. The product addresses a significant unmet need in patients requiring long-term NSAID therapy, particularly those at risk of gastrointestinal complications.

RPG Life Sciences Limited

RPG Life Sciences Limited and Ipca Laboratories Limited have announced the completion of dispatch of Notice of Annual General Meeting (AGM) and the facility to exercise right to vote on agenda items through electronic means. Ipca Laboratories Limited will hold its 76th AGM on August 13, 2026, through Video Conferencing / Other Audio Visual Means (VC/OAVM).

RPG Life Sciences Limited

RPG Life Sciences Limited has sent a letter to shareholders whose email addresses are not registered with the company or its registrar, stating the web-link where the Annual Report is uploaded on the website. The company has also informed shareholders about the 19th Annual General Meeting (AGM) scheduled to be held on July 23, 2026, and the Annual Report for the Financial Year 2025-26 is available on the company's website and other stock exchange websites.

RPG Life Sciences Limited

RPG Life Sciences Limited has announced its 19th Annual General Meeting (AGM) to be held on July 23, 2026, through video conferencing. The company has submitted its Annual Report for the financial year 2025-26, including the Business Responsibility and Sustainability Report, to the members of the company.

RPG Life Sciences Limited

RPG Life Sciences Limited has closed its trading window for insiders due to SEBI regulations, effective from July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending June 30, 2026.

RPG Life Sciences Limited

RPG Life Sciences Limited announced the publication of newspaper advertisements in Business Standard and Mumbai-Lakshadeep. These advertisements notify stakeholders about the company's Nineteenth Annual General Meeting (AGM), which will be held on Thursday, July 23, 2026, at 3:00 p.m. (IST) via Video Conferencing / Other Audio Visual Means. This disclosure is in compliance with applicable SEBI Listing Regulations and Ministry of Corporate Affairs circulars.

RPG Life Sciences Limited

RPG Life Sciences Limited announced that its Board of Directors recommended a final dividend of Rs. 24/- (300%) per equity share for the financial year ended March 31, 2026. This dividend is subject to approval by shareholders at the Nineteenth Annual General Meeting scheduled for July 23, 2026. The company has fixed Thursday, July 9, 2026, as the Record Date to determine the eligibility of members for this dividend, which, if approved, will be paid within 30 days of the AGM.